246 related articles for article (PubMed ID: 19183146)
1. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.
Nocon M; Labenz J; Jaspersen D; Leodolter A; Richter K; Vieth M; Lind T; Malfertheiner P; Willich SN
Aliment Pharmacol Ther; 2009 Mar; 29(6):662-8. PubMed ID: 19183146
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
Aliment Pharmacol Ther; 2007 Mar; 25(6):715-22. PubMed ID: 17311605
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
6. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD.
Brozek JL; Guyatt GH; Heels-Ansdell D; Degl'Innocenti A; Armstrong D; Fallone CA; Wiklund I; van Zanten SV; Chiba N; Barkun AN; Akl EA; Schünemann HJ
J Clin Epidemiol; 2009 Jan; 62(1):102-10. PubMed ID: 18619804
[TBL] [Abstract][Full Text] [Related]
7. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Noar MD; Lotfi-Emran S
Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
[TBL] [Abstract][Full Text] [Related]
8. Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany.
Madisch A; Kulich KR; Malfertheiner P; Ziegler K; Bayerdörffer E; Miehlke S; Labenz J; Carlsson J; Wiklund IK
Z Gastroenterol; 2003 Dec; 41(12):1137-43. PubMed ID: 14661122
[TBL] [Abstract][Full Text] [Related]
9. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
Wahlqvist P; Karlsson M; Johnson D; Carlsson J; Bolge SC; Wallander MA
Aliment Pharmacol Ther; 2008 May; 27(10):960-70. PubMed ID: 18315585
[TBL] [Abstract][Full Text] [Related]
10. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
12. Burden of gastroesophageal reflux disease in Shanghai, China.
Wang R; Yan X; Ma XQ; Cao Y; Wallander MA; Johansson S; He J
Dig Liver Dis; 2009 Feb; 41(2):110-5. PubMed ID: 18706874
[TBL] [Abstract][Full Text] [Related]
13. Burden of illness in patients with reflux disease--evidence from a recent comparative methodological study in Hungary.
Ujszászy L; Kulich RK; Tóth GT; Bárány L; Carlsson J; Wiklund I
Orv Hetil; 2004 Mar; 145(13 Suppl 2):717-22, 733-8. PubMed ID: 15125324
[TBL] [Abstract][Full Text] [Related]
14. Validation of a quality-of-life instrument for laryngopharyngeal reflux.
Carrau RL; Khidr A; Gold KF; Crawley JA; Hillson EM; Koufman JA; Pashos CL
Arch Otolaryngol Head Neck Surg; 2005 Apr; 131(4):315-20. PubMed ID: 15837899
[TBL] [Abstract][Full Text] [Related]
15. Does laparoscopic antireflux surgery improve quality of life in patients whose gastro-oesophageal reflux disease is well controlled with medical therapy?
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2008 May; 20(5):430-5. PubMed ID: 18403945
[TBL] [Abstract][Full Text] [Related]
16. Psychometric validation of the Hungarian translation of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with reflux disease.
Kulich RK; Ujszászy L; Tóth GT; Bárány L; Carlsson J; Wiklund I
Orv Hetil; 2004 Mar; 145(13 Suppl 2):723-9, 739-44. PubMed ID: 15125325
[TBL] [Abstract][Full Text] [Related]
17. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Malfertheiner P; Nocon M; Vieth M; Stolte M; Jaspersen D; Koelz HR; Labenz J; Leodolter A; Lind T; Richter K; Willich SN
Aliment Pharmacol Ther; 2012 Jan; 35(1):154-64. PubMed ID: 22070159
[TBL] [Abstract][Full Text] [Related]
18. Measuring the effectiveness of laparoscopic antireflux surgery: long-term results.
Gee DW; Andreoli MT; Rattner DW
Arch Surg; 2008 May; 143(5):482-7. PubMed ID: 18490558
[TBL] [Abstract][Full Text] [Related]
19. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
Bardhan KD; Berghöfer P
Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
[TBL] [Abstract][Full Text] [Related]
20. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
